HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (6) , 224-230
- https://doi.org/10.1016/s1357-4310(00)01699-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSINGAnnual Review of Immunology, 1998
- Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium.Journal of Clinical Investigation, 1998
- Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.Journal of Clinical Investigation, 1996
- Presentation of HLA Class I‐Derived Peptides: Potential Involvement in Allorecognition and HLA‐B27‐Associated ArthritisImmunological Reviews, 1996
- Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV diseaseQJM: An International Journal of Medicine, 1996
- Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.The Journal of Experimental Medicine, 1995
- HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic miceHuman Immunology, 1995
- Differences in peptide presentation between B27 subtypes: The importance of the P1 side chain in maintaining high affinity peptide binding to B★2703Immunity, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993